Representative before the EPO

Employment test 1 - 10 employees
Company dna dehmel and bettenhausen
no operation time available
Headquarter in Munich and 1 office
active in Legal Services and IP Consulting

Florian Rückerl has worked on the following 51 EPO patent applications which have been published in the last five years:

EP11739219

METHODS FOR FRACTIONING WHEY PROTEIN ISOLATES

IPC classification:
A23J 1/20, A23J 3/08
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP12711484

CARDIAC REPAIR BY REPROGRAMMING OF CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES

IPC classification:
A61K 38/17, A61K 48/00, C07K 14/47, C12N 5/077
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP12713737

A METHOD FOR CONTROLLING THE MAIN COMPLEX N-GLYCAN STRUCTURES AND THE ACIDIC VARIANTS AND VARIABILITY IN BIOPROCESSES PRODUCING RECOMBINANT PROTEINS

IPC classification:
C07K 14/43, C07K 14/435, C12N 5/00
Applicant:
LEK Pharmaceuticals dd
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP12717317

NEW ANTIMICROBIAL AGENTS

IPC classification:
C07K 14/005
Applicant:
Lysando AG
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12814909

ADENOVIRUS E1A FRAGMENTS FOR USE IN ANTI-CANCER THERAPIES

IPC classification:
A61K 38/16, C07K 14/005
Applicant:
Saint Louis University
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
PATENT GRANTED
EP12761867

5-METHOXY. 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND METHODS FOR NUCLEIC ACID SEQUENCING

IPC classification:
C07H 19/073, C07H 19/10, C07H 19/173, C07H 19/20
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP12774049

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROMYELITIS OPTICA

IPC classification:
A61K 39/00, A61P 25/00
Applicant:
The Regents of the University of Colorado
Agent:
Martin Weber, Jones Day
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP12790523

COMPOSITION FOR PROTECTION AGAINST CELL-DAMAGING EFFECTS

IPC classification:
A23L 1/03, A61K 31/122, A61K 31/198, A61K 31/225, A61K 31/375, A61K 31/455, A61K 31/522, A61P 39/06
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP12856300

METHODS AND COMPOSITIONS FOR TREATING VIRAL DISEASES

IPC classification:
A61K 31/517
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP11827555

METHODS OF TREATING CANCER COMPRISING TARGETING NQO1

IPC classification:
A61K 31/22, A61P 35/00, C12Q 1/68
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Agent:
Jarkko Kortesmaa, Zacco Sweden AB
Status:
EXAMINATION IN PROGRESS
EP13743712

INJECTION DEVICES

IPC classification:
A61M 5/31, A61M 5/46
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
PATENT GRANTED
EP13709667

SYNTHETIC LIPID BIOLOGY FOR COMBINATORIAL ENGINEERING OF ENDOTOXIN

IPC classification:
C12N 15/10, C12N 15/70
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP13767943

EFFICIENT SYNTHESIS OF ETHYLENEDICYSTEINE-SUGAR CONJUGATES FOR IMAGING AND THERAPY

IPC classification:
A61K 31/425, A61K 31/70, A61K 49/06, C07D 277/04, C07D 277/06
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP13772672

MULTICOLORED PH-ACTIVATABLE FLUORESCENCE NANOPLATFORM

IPC classification:
A61K 9/127
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP14193656

Oncolytic Farmington rhabdovirus

IPC classification:
A61K 35/76, A61K 35/761, A61K 35/763, A61K 35/766, A61K 35/768, A61K 45/06, A61P 35/00, A61P 35/04, C12N 7/00
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP13791038

CELLULAR VACCINE AND METHOD OF INDUCING AN IMMUNE RESPONSE IN A SUBJECT

IPC classification:
A61K 31/711, A61K 39/00, A61K 39/21, A61K 39/29, A61P 37/04, C12N 5/0784, C12N 15/62
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP13827577

ANTIMICROBIAL COMPOSITIONS COMPRISING GLYCERYL NITRATES

IPC classification:
A61K 31/045, A61K 31/21, A61P 31/00, A61P 31/04
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP13836620

MODULATION OF PODOPLANIN MEDIATED PLATELET ACTIVATION

IPC classification:
A61K 38/00, A61P 7/04
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP13786389

JAM-C ANTIBODIES AND METHODS FOR TREATMENT OF CANCER

IPC classification:
C07K 16/28
Applicant:
Research Development Foundation
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP11709133

IN VITRO PROCESS FOR THE QUICK DETERMINATION OF A PATIENT'S STATUS RELATING TO INFECTION WITH MYCOBACTERIUM TUBERCULOSIS

IPC classification:
G01N 33/50, G01N 33/569
Agent:
dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP13814447

METHOD FOR DETERMINING COMPATIBILITY BETWEEN A DONOR AND A RECIPIENT BY MEANS OF THE FLOW CYTOMETRIC DETECTION OF ALLOREACTIVE T CELLS

IPC classification:
G01N 33/50, G01N 33/569, G01N 33/68
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP13857737

HUMANIZED MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C AND USES THEREOF

IPC classification:
A61K 39/395, C12N 15/63, C12P 21/06
Applicant:
Bayer Healthcare LLC
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Agent:
Bayer Intellectual Property GmbH
Status:
GRANT OF PATENT INTENDED
EP15151109

Anti-OX40 antibodies and methods of using the same

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C12N 15/13
Applicant:
The Board of Regents of the University of Texas System
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP13869967

RAPAMYCIN ANALOGS TARGETING PROTEASOME FUNCTION IN THE TREATMENT OF CANCER

IPC classification:
A61P 35/00
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP13814441

A METHOD FOR RECOGNITION OF A PRESENCE OF AN INFECTION WITH CMV

IPC classification:
G01N 33/569
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP14742935

RECOMBINANT ANTIGENS OF PORCINE CIRCOVIRUS 2 (PCV-2) FOR VACCINE FORMULATIONS, DIAGNOSTIC KIT AND USE THEREOF

IPC classification:
A61K 39/12, A61P 31/20, C07K 14/01, C12N 15/34, G01N 33/53
Applicant:
UFV (Universidade Federal de Viçosa)
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP14760783

SPECIFIC DETECTION TOOL FOR MESENCHYMAL AND EPITHELIAL-MESENCHYMAL TRANSFORMED CIRCULATING TUMOR CELLS

IPC classification:
A61K 39/395, C07K 16/18
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14772555

HER3 SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, G01N 33/574
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15187399

NEW ANTIMICROBIAL AGENTS

IPC classification:
C07K 14/005
Applicant:
Lysando AG
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14800355

TREATMENT OF NEUROLOGICAL AND OTHER DISORDERS

IPC classification:
A61K 31/485, A61K 31/5513, A61K 31/5517, A61P 25/00
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14766012

TENDON REPAIR SYSTEMS, DEVICES, AND KITS

IPC classification:
A61B 17/04, A61B 17/11
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP14853799

COMPOSITIONS AND METHODS OF ADMINISTERING SAME

IPC classification:
A61K 31/137, A61K 31/4168, A61K 31/485, A61K 31/5517, A61P 25/30, A61P 25/32, A61P 25/34, A61P 25/36
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP11779450

NUCLEAR DNA CONTENT OF CHO CELL LINES AS A SELECTION CRITERION IN SCREENING OF THE BEST RECOMBINANT PROTEIN PRODUCERS

IPC classification:
C12N 15/67, C12P 21/00, C12Q 1/68
Applicant:
LEK Pharmaceuticals dd
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11778880

NOVEL ENDOLYSIN

IPC classification:
A61K 38/46, C12N 9/36, C12N 9/52
Applicant:
Katholieke Universiteit Leuven
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14815479

BIPHENYLAMIDE DERIVATIVE HSP90 INHIBITORS

IPC classification:
A61K 31/167, A61K 31/4465, A61P 35/00, C07C 235/56, C07D 207/08, C07D 211/22, C07D 211/46, C07D 401/12, C07D 451/06
Applicant:
University of Kansas
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14799418

MODIFIED KZ144 ENDOLYSIN SEQUENCE

IPC classification:
C12N 9/36, C12N 9/50
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP14799422

MODIFIED EL188 ENDOLYSIN SEQUENCE

IPC classification:
A61K 38/00, C12N 9/36, C12N 15/62
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14864015

INHIBITORS OF HSV NUCLEOTIDYL TRANSFERASES AND USES THEREFOR

IPC classification:
A01N 35/00, A61K 31/12, C07C 49/00
Applicant:
Saint Louis University
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15746353

AMINOTRIAZOLE- AND AMINOTETRAZOLE-BASED KDM1A INHIBITORS AS EPIGENETIC MODULATORS

IPC classification:
A01N 43/40, A01N 43/64, C07D 249/14, C07D 401/00
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15705587

ANTIMICROBIAL AGENTS

IPC classification:
C12N 9/36, C12N 9/80, C12N 15/62
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP15743631

DRAINAGE TREATMENT SYSTEM

IPC classification:
B01D 29/00, E02B 15/04, E03F 5/14
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15715243

PHARMACEUTICAL COMPOSITION AGAINST CHRONIC BACTERIAL INFECTIONS

IPC classification:
A61K 38/46, A61P 31/04
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14889332

MULTIPLE SPEED PROCESS FOR PRESERVING HEAT SENSITIVE PORTIONS OF A THERMOKINETICALLY MELT BLENDED BATCH

IPC classification:
B01F 3/00, B01F 7/00, B01F 7/02, B01F 7/04
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15798855

NOVEL COMPOUNDS SUPPORTS HEMATOPOIETIC STEM CELLS AND RED BLOOD CELLS

IPC classification:
A61K 31/155, C07C 279/14
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15733579

TRIAZOLE MODIFIED COUMARIN AND BIPHENYL AMIDE-BASED HSP90 INHIBITORS

IPC classification:
A61K 31/454, A61P 35/00, C07D 401/12, C07D 405/14
Applicant:
University of Kansas
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15806650

TEXAPHYRIN-PT(IV) CONJUGATES AND COMPOSITIONS FOR USE IN OVERCOMING PLATINUM RESISTANCE

IPC classification:
A61K 31/40, A61P 35/00, A61K 47/50
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14894941

USB TERMINAL-EQUIPPED BATTERY

IPC classification:
H01M 2/30, H01M 10/46
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15834874

FORMULATIONS OF TESTOSTERONE AND METHODS OF TREATMENT THEREWITH

IPC classification:
A61K 31/56
Applicant:
The Board of Regents of the University of Texas System
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15842037

SYRINGE INFUSION DEVICES AND SYSTEMS FOR DELIVERY OF ACTIVE AGENTS

IPC classification:
A61M 5/145
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
Request for examination was made
EP15842717

VIRAL RNA SEGMENTS AS IMMUNOMODULATORY AGENTS AND VACCINE COMPONENTS

IPC classification:
A61K 39/12, A61K 39/29, C07K 14/005, C07K 14/18, C12N 15/00, C12N 15/11
Applicant:
University of Iowa Research Foundation
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
Request for examination was made

Please Sign in to use this feature